Clinical Trials
89 trialsAcquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Massachusetts General Hospital
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Dana-Farber Cancer Institute
Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)
University of Utah
EWOG MDS 2006
University Hospital Freiburg
ENKLA-M
Nantes University Hospital
CER
Cancer Support Community, Research and Training Institute, Philadelphia
CYTOK-AZA
Nantes University Hospital
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Wake Forest University Health Sciences
CHIS
Assistance Publique - Hôpitaux de Paris
MDS & PRRT
University Health Network, Toronto
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Washington University School of Medicine
Pathogenesis of Hematologic Malignancies
OHSU Knight Cancer Institute
NICHE
Institute of Hematology & Blood Diseases Hospital, China
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
Rigshospitalet, Denmark
Activity Levels in Bone Marrow Transplant Patients
University of Iowa
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
REBOUND
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Umbilical Cord Blood Transplantation From Unrelated Donors
University of Rochester
HALO-SCT
Affiliated Hospital of Qinghai University
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
City of Hope Medical Center
MRD
University of Rochester
Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
Asan Medical Center
Muscle Dysfunction in Patients With Haematological Diseases
Rigshospitalet, Denmark
OURA MDS
Sunnybrook Health Sciences Centre
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy
Dana-Farber Cancer Institute
SDS-GPS
Shwachman-Diamond Syndrome Alliance Inc
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Groupe Francophone des Myelodysplasies
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Ann & Robert H Lurie Children's Hospital of Chicago
Blood Samples to Identify Biomarkers of Busulfan
Fred Hutchinson Cancer Center
GITMO AML/MDS-Relapse Registry Study
Gruppo Italiano Trapianto di Midollo Osseo
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
Myeloproliferative Neoplasms (MPNs) Patient Registry
University Health Network, Toronto
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Alliance for Clinical Trials in Oncology
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Gruppo Italiano Malattie EMatologiche dell'Adulto
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
Qianfoshan Hospital
SARS-CoV-2 Donor-Recipient Immunity Transfer
City of Hope Medical Center
Registry on Hypomethylating Agents in Myeloid Neoplasms
Arbeitsgemeinschaft medikamentoese Tumortherapie
EMATO0113
Gruppo Italiano Malattie EMatologiche dell'Adulto
BMP-MDS
Hospices Civils de Lyon
Chemobrain
University of Nebraska
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
Fred Hutchinson Cancer Center
COSMOS
Centre Hospitalier Universitaire de Saint Etienne
DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US
The Cleveland Clinic
AML-MDS Novel Prognostic Tests Clinical Study
Nova Scotia Health Authority
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease
M.D. Anderson Cancer Center
BUFLU
Grupo Espanol de trasplantes hematopoyeticos y terapia celular
Collecting and Storing Blood Samples From Patients With Cancer
Rutgers, The State University of New Jersey
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Grupo Cooperativo de HemopatÃas Malignas
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Memorial Sloan Kettering Cancer Center